Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

2.

Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors.

Prasad ML, Pellegata NS, Huang Y, Nagaraja HN, de la Chapelle A, Kloos RT.

Mod Pathol. 2005 Jan;18(1):48-57.

3.

Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC.

Prasad ML, Huang Y, Pellegata NS, de la Chapelle A, Kloos RT.

Histopathology. 2004 Jul;45(1):39-46.

PMID:
15228442
4.

Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: Utility of HBME1 combined with CK19 immunostaining.

Nasr MR, Mukhopadhyay S, Zhang S, Katzenstein AL.

Mod Pathol. 2006 Dec;19(12):1631-7. Epub 2006 Sep 22.

5.

Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma.

Mai KT, Landry DC, Thomas J, Burns BF, Commons AS, Yazdi HM, Odell PF.

Histopathology. 2001 Jul;39(1):25-32.

PMID:
11454041
6.

Expression of cytokeratin 19, HBME-1 and galectin-3 in neoplastic and nonneoplastic thyroid lesions.

Mataraci EA, Ozgüven BY, Kabukçuoglu F.

Pol J Pathol. 2012 Mar;63(1):58-64.

7.

Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.

Zhu X, Sun T, Lu H, Zhou X, Lu Y, Cai X, Zhu X.

J Clin Pathol. 2010 Sep;63(9):786-9. doi: 10.1136/jcp.2010.076901. Epub 2010 Jul 19.

PMID:
20644217
8.

Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.

El Demellawy D, Nasr AL, Babay S, Alowami S.

Pathol Res Pract. 2009;205(5):303-9. doi: 10.1016/j.prp.2008.11.011. Epub 2009 Jan 18.

PMID:
19153015
10.

Differential expression of galectin-3 in papillary projections of malignant and non-malignant hyperplastic thyroid lesions.

Cvejić D, Savin S, Petrović I, Paunović I, Tatić S, Havelka M.

Acta Chir Iugosl. 2003;50(3):67-70.

PMID:
15179758
11.

Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution.

Sahoo S, Hoda SA, Rosai J, DeLellis RA.

Am J Clin Pathol. 2001 Nov;116(5):696-702.

PMID:
11710686
12.

Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases.

Woodford RL, Nikiforov YE, Hunt JL, Bellizzi AM, Zhang X, Mills SE, Stelow EB.

Am J Surg Pathol. 2010 Nov;34(11):1582-90. doi: 10.1097/PAS.0b013e3181f2d820.

PMID:
20924280
13.

[Expression of Twist in papillary thyroid carcinomas and its roles in differential diagnosis].

He CN, He L, Cheng JQ, Chen SC, Zhao HF, Zhai JP, Zhang J.

Zhonghua Bing Li Xue Za Zhi. 2008 Jan;37(1):35-9. Chinese.

PMID:
18509983
14.

Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma.

Jakubiak-Wielganowicz M, Kubiak R, Sygut J, Pomorski L, Kordek R.

Pol J Pathol. 2003;54(2):111-5.

PMID:
14575419
16.

Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy.

de Matos PS, Ferreira AP, de Oliveira Facuri F, Assumpção LV, Metze K, Ward LS.

Histopathology. 2005 Oct;47(4):391-401.

PMID:
16178894
17.

Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China.

Song Q, Wang D, Lou Y, Li C, Fang C, He X, Li J.

Diagn Pathol. 2011 Dec 21;6:126. doi: 10.1186/1746-1596-6-126.

18.
19.

Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.

Than TH, Swethadri GK, Wong J, Ahmad T, Jamil D, Maganlal RK, Hamdi MM, Abdullah MS.

Singapore Med J. 2008 Apr;49(4):333-8.

20.

Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal.

Liu Z, Zhou G, Nakamura M, Koike E, Li Y, Ozaki T, Mori I, Taniguchi E, Kakudo K.

Cancer Sci. 2011 Jan;102(1):288-94. doi: 10.1111/j.1349-7006.2010.01769.x. Epub 2010 Nov 10.

Supplemental Content

Support Center